PIDILITIND - Investment Analysis: Buy Signal or Bull Trap?
Last Updated Time : 20 Dec 25, 07:10 am
Back to Investment ListInvestment Rating: 3.9
| Stock Code | PIDILITIND | Market Cap | 1,48,759 Cr. | Current Price | 1,462 ₹ | High / Low | 1,575 ₹ |
| Stock P/E | 66.7 | Book Value | 92.8 ₹ | Dividend Yield | 0.69 % | ROCE | 30.5 % |
| ROE | 23.2 % | Face Value | 1.00 ₹ | DMA 50 | 1,479 ₹ | DMA 200 | 1,491 ₹ |
| Chg in FII Hold | -0.05 % | Chg in DII Hold | 0.00 % | PAT Qtr | 586 Cr. | PAT Prev Qtr | 650 Cr. |
| RSI | 42.1 | MACD | -5.13 | Volume | 2,68,718 | Avg Vol 1Wk | 3,42,910 |
| Low price | 1,310 ₹ | High price | 1,575 ₹ | PEG Ratio | 3.27 | Debt to equity | 0.03 |
| 52w Index | 57.2 % | Qtr Profit Var | 8.10 % | EPS | 21.8 ₹ | Industry PE | 26.6 |
📊 Analysis: PIDILITIND demonstrates strong fundamentals with ROE (23.2%) and ROCE (30.5%) reflecting excellent capital efficiency. Debt-to-equity ratio (0.03) indicates a virtually debt-free balance sheet, adding financial stability. Dividend yield (0.69%) provides minor income support. However, valuations are stretched with P/E (66.7) vs industry PE (26.6) and PEG ratio (3.27), suggesting overvaluation relative to growth. Current price (₹1,462) is slightly below DMA 50 (₹1,479) and DMA 200 (₹1,491), showing weak technical trend. RSI (42.1) and MACD (-5.13) indicate cautious momentum. Quarterly PAT declined from ₹650 Cr. to ₹586 Cr., though YoY growth (+8.10%) remains positive. Long-term compounding potential exists due to strong efficiency and brand leadership, but entry should be cautious given valuations.
💰 Ideal Entry Zone: ₹1,350 – ₹1,450 (near support levels and valuation comfort). This provides margin of safety for long-term investors.
📈 Exit / Holding Strategy: For existing holders, maintain positions for 3–5 years given strong ROE/ROCE and debt-free status. Consider partial profit booking near ₹1,550–₹1,575 resistance. Exit only if price sustains below ₹1,310 with weakening fundamentals. Long-term holding is favorable for compounding growth, though valuations may cap upside.
Positive
- ✅ Strong ROE (23.2%) and ROCE (30.5%)
- ✅ Debt-to-equity ratio very low (0.03)
- ✅ Dividend yield (0.69%) adds minor stability
- ✅ EPS of ₹21.8 supports earnings base
- ✅ Consistent YoY profit growth (+8.10%)
Limitation
- ⚠️ High P/E (66.7) vs industry PE (26.6)
- ⚠️ PEG ratio (3.27) indicates overvaluation
- ⚠️ Current price below DMA 50 & DMA 200 (weak trend)
- ⚠️ RSI and MACD show cautious momentum
- ⚠️ FII holdings decreased (-0.05%)
Company Negative News
- 📉 Quarterly PAT declined from ₹650 Cr. to ₹586 Cr.
- 📉 Technical indicators show weak momentum
- 📉 FII stake reduced (-0.05%)
Company Positive News
- 📢 Strong efficiency ratios (ROE & ROCE)
- 📢 Debt-free structure ensures financial flexibility
- 📢 Consistent YoY profit growth (+8.10%)
Industry
- 🏦 Industry PE at 26.6 vs PIDILITIND’s 66.7, showing overvaluation
- 🏦 Specialty chemicals/adhesives sector has strong long-term demand drivers
Conclusion
🔑 PIDILITIND is a fundamentally strong company with excellent efficiency and debt-free status, but valuations are stretched. Entry near ₹1,350–₹1,450 offers margin of safety. Long-term holding (3–5 years) is favorable for compounding growth, with partial profit booking near resistance levels. Conservative investors should wait for valuation comfort before committing to extended positions.
Would you like me to prepare a peer benchmarking overlay comparing PIDILITIND with other specialty chemical and adhesive peers (like Asian Paints, Berger Paints, and Astral) to highlight stronger compounding opportunities?
Back to Investment ListNIFTY 50 - Today Top Investment Picks Stock Picks
NEXT 50 - Today Top Investment Picks Stock Picks
MIDCAP - Today Top Investment Picks Stock Picks
SMALLCAP - Today Top Investment Picks Stock Picks